PHARMA
PHARMAPharmaceutical Hydrogenation Membrane in India
Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. India's National Green Hydrogen Mission commits INR 19,744 crore to building a domestic green hydrogen ecosystem.
Market Context
IndiaPolicy
H₂ Target
Cities
Industries
Ultra-Clean Hydrogen Source
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
GMP-Compatible On-Site Generation
On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.
Batch-Flexible Operation
Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.
Pharmaceutical Hydrogenation in India’s Hydrogen Market
India's National Green Hydrogen Mission commits INR 19,744 crore to building a domestic green hydrogen ecosystem. The country targets 125 GW of electrolyser capacity by 2030, creating massive demand for high-performance AWE separator membranes. With refineries, fertilizer plants, and steel mills concentrated across Gujarat, Maharashtra, and Tamil Nadu, India represents the fastest-growing alkaline electrolysis market globally.
IONZERA is manufactured by G-Hexa Research Center in Bengaluru, making it the only domestically produced high-performance AWE membrane in India. This eliminates import duties, reduces lead times to 2-5 days for any Indian city, and aligns with Make in India and Atmanirbhar Bharat objectives. Indian electrolyser OEMs and project developers benefit from rupee-denominated pricing and direct technical support.
Lower Resistance
Thinner Profile
PERFORMANCE ADVANTAGE
Why IONZERA for Pharmaceutical Hydrogenation in India
Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.
Shipping & Logistics
Shipped from Bengaluru manufacturing facility. 1-2 day delivery to South India, 2-3 days to West and Central India, 3-5 days to North and East India via road freight. Express air cargo available for urgent requirements.
Area Resistance
3x LOWERThickness
20% THINNERFrequently Asked Questions
Why choose IONZERA for pharmaceutical hydrogenation in India?
IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in India. IONZERA is manufactured by G-Hexa Research Center in Bengaluru, making it the only domestically produced high-performance AWE membrane in India.
Is IONZERA manufactured in India?
Yes. IONZERA is manufactured by G-Hexa Research Center in Bengaluru, Karnataka. It is the only high-performance AWE separator membrane produced domestically in India, eliminating import dependency for this critical electrolyser component.
How does IONZERA support the National Green Hydrogen Mission?
IONZERA directly supports NGHM by providing a domestically manufactured, high-performance membrane that reduces electrolyser costs. Its 3x lower resistance compared to imported alternatives improves hydrogen production efficiency, helping India achieve its 5 MT green hydrogen target by 2030.
EXPLORE MORE
Request Pharmaceutical Hydrogenation Samples for India
Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for India-based projects.
Request Sample